We are live on
!
Find out more
LIM
Lagoda Investment Management Portfolio holdings
AUM
$162M
1-Year Est. Return
49.7%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$375M
AUM Growth
–
Cap. Flow
+$370M
Cap. Flow
% of AUM
98.82%
Top 10 Holdings %
Top 10 Hldgs %
68.18%
Holding
47
New
47
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$37.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$36.3M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$26.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$25.3M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$24.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.56% |
| 2 | Financials | 21.42% |
| 3 | Communication Services | 6.63% |
| 4 | Materials | 5.99% |
| 5 | Technology | 5.87% |
Similar funds
PCP
AXA
KCPT
TFP
CWMGO
SWMG
TIAM2
GWM
Lagoda Investment Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Lagoda Investment Management, which disclosed 47 positions worth $375M. Its ten largest holdings account for 68% of the portfolio.
Its largest position is Alexion Pharmaceuticals: 200,465 shares worth $37.1M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, followed by Financials and Communication Services.
- Lagoda Investment Management's largest Q4 2014 buy was Alexion Pharmaceuticals: 200,465 shares worth $37.1M.
- Lagoda Investment Management's ten largest holdings make up 68% of its $375M portfolio in Q4 2014.
- Lagoda Investment Management disclosed 47 positions in Q4 2014, its first 13F filing on record.
Based on Lagoda Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.